Ascentage Pharma Group International (AAPG) Competitors $18.90 +0.23 (+1.23%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends AAPG vs. CYTK, AXSM, TGTX, VRNA, GRFS, KRYS, RARE, RNA, ADMA, and BHVNShould you be buying Ascentage Pharma Group International stock or one of its competitors? The main competitors of Ascentage Pharma Group International include Cytokinetics (CYTK), Axsome Therapeutics (AXSM), TG Therapeutics (TGTX), Verona Pharma (VRNA), Grifols (GRFS), Krystal Biotech (KRYS), Ultragenyx Pharmaceutical (RARE), Avidity Biosciences (RNA), ADMA Biologics (ADMA), and Biohaven (BHVN). These companies are all part of the "pharmaceutical products" industry. Ascentage Pharma Group International vs. Cytokinetics Axsome Therapeutics TG Therapeutics Verona Pharma Grifols Krystal Biotech Ultragenyx Pharmaceutical Avidity Biosciences ADMA Biologics Biohaven Ascentage Pharma Group International (NASDAQ:AAPG) and Cytokinetics (NASDAQ:CYTK) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and community ranking. Does the MarketBeat Community believe in AAPG or CYTK? Cytokinetics received 814 more outperform votes than Ascentage Pharma Group International when rated by MarketBeat users. CompanyUnderperformOutperformAscentage Pharma Group InternationalN/AN/ACytokineticsOutperform Votes81479.88% Underperform Votes20520.12% Does the media favor AAPG or CYTK? In the previous week, Cytokinetics had 23 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 25 mentions for Cytokinetics and 2 mentions for Ascentage Pharma Group International. Cytokinetics' average media sentiment score of 0.41 beat Ascentage Pharma Group International's score of -0.50 indicating that Cytokinetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Cytokinetics 5 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Which has preferable valuation and earnings, AAPG or CYTK? Ascentage Pharma Group International has higher earnings, but lower revenue than Cytokinetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group InternationalN/AN/AN/AN/AN/ACytokinetics$7.53M661.51-$526.24M-$5.38-7.85 Is AAPG or CYTK more profitable? Ascentage Pharma Group International has a net margin of 0.00% compared to Cytokinetics' net margin of -17,906.25%. Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Cytokinetics -17,906.25%N/A -50.21% Do analysts prefer AAPG or CYTK? Cytokinetics has a consensus target price of $83.00, indicating a potential upside of 96.64%. Given Cytokinetics' stronger consensus rating and higher probable upside, analysts plainly believe Cytokinetics is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cytokinetics 0 Sell rating(s) 2 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.88 SummaryCytokinetics beats Ascentage Pharma Group International on 7 of the 9 factors compared between the two stocks. Get Ascentage Pharma Group International News Delivered to You Automatically Sign up to receive the latest news and ratings for AAPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AAPG vs. The Competition Export to ExcelMetricAscentage Pharma Group InternationalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.49B$6.92B$5.69B$9.04BDividend YieldN/A2.91%5.30%4.01%P/E RatioN/A9.6589.7819.46Price / SalesN/A324.021,038.3174.14Price / CashN/A75.4646.0638.79Price / BookN/A5.635.134.78Net IncomeN/A$123.93M$113.50M$222.19M7 Day PerformanceN/A-0.20%0.42%1.42%1 Month PerformanceN/A-0.44%3.65%2.91%1 Year PerformanceN/A5.40%22.50%20.50% Ascentage Pharma Group International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AAPGAscentage Pharma Group InternationalN/A$18.90+1.2%N/AN/A$1.49BN/A0.00600CYTKCytokinetics4.2345 of 5 stars$42.76-7.4%$83.00+94.1%-44.4%$5.45B$7.53M-7.95250Analyst ForecastAnalyst RevisionHigh Trading VolumeAXSMAxsome Therapeutics4.289 of 5 stars$105.76-3.4%$134.00+26.7%+9.2%$5.31B$270.60M-16.20380Analyst ForecastNews CoverageGap UpTGTXTG Therapeutics4.348 of 5 stars$33.09-1.2%$40.67+22.9%+124.5%$5.21B$233.66M-330.87290VRNAVerona Pharma2.0026 of 5 stars$60.26-1.6%$53.14-11.8%+254.3%$4.90B$460,000.00-31.3930GRFSGrifols1.7984 of 5 stars$7.12+1.9%N/A-14.0%$4.81B$7.13B0.0023,737Gap DownKRYSKrystal Biotech4.8143 of 5 stars$154.87-3.8%$206.67+33.4%+39.1%$4.63B$50.70M87.50210RAREUltragenyx Pharmaceutical4.5548 of 5 stars$45.35-0.9%$92.43+103.8%-3.0%$4.23B$434.25M-7.011,276RNAAvidity Biosciences1.3307 of 5 stars$34.92-0.5%$65.80+88.4%+161.6%$4.19B$9.56M-12.13190ADMAADMA Biologics4.0299 of 5 stars$16.71-1.2%$21.25+27.2%+218.9%$4.00B$258.21M59.68530Gap DownBHVNBiohaven2.8665 of 5 stars$38.40-1.2%$63.00+64.1%-20.9%$3.93BN/A-4.11239Positive News Related Companies and Tools Related Companies CYTK Alternatives AXSM Alternatives TGTX Alternatives VRNA Alternatives GRFS Alternatives KRYS Alternatives RARE Alternatives RNA Alternatives ADMA Alternatives BHVN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AAPG) was last updated on 2/10/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | SponsoredBill O’Reilly: “the best-prepared president in history.”"We're going to bring back the American Dream... bigger, better, bolder, richer, safer, and stronger than ever...The Oxford Club | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
